Danaher Company Profile (NYSE:DHR)

About Danaher (NYSE:DHR)

Danaher logoDanaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Industrial Conglomerates
  • Symbol: NYSE:DHR
  • CUSIP: 23585110
  • Web: www.danaher.com/
  • Market Cap: $59.23 billion
  • Outstanding Shares: 694,689,000
Average Prices:
  • 50 Day Moving Avg: $85.95
  • 200 Day Moving Avg: $84.19
  • 52 Week Range: $75.71 - $88.62
  • Trailing P/E Ratio: 27.21
  • Foreward P/E Ratio: 19.87
  • P/E Growth: 2.44
Sales & Book Value:
  • Annual Revenue: $17.43 billion
  • Price / Sales: 3.40
  • Book Value: $35.40 per share
  • Price / Book: 2.41
  • Annual Dividend: $0.56
  • Dividend Yield: 0.6%
  • EBITDA: $4.16 billion
  • Net Margins: 12.36%
  • Return on Equity: 9.24%
  • Return on Assets: 4.92%
  • Debt-to-Equity Ratio: 0.46%
  • Current Ratio: 1.49%
  • Quick Ratio: 1.06%
  • Average Volume: 2.70 million shs.
  • Beta: 1.03
  • Short Ratio: 1.21

Frequently Asked Questions for Danaher (NYSE:DHR)

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher announced a quarterly dividend on Tuesday, September 12th. Investors of record on Friday, September 29th will be paid a dividend of $0.14 per share on Friday, October 27th. This represents a $0.56 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, September 28th. View Danaher's Dividend History.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) issued its quarterly earnings data on Thursday, July, 20th. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher had a return on equity of 9.24% and a net margin of 12.36%. Danaher's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.90 earnings per share. View Danaher's Earnings History.

When will Danaher make its next earnings announcement?

Danaher is scheduled to release their next quarterly earnings announcement on Thursday, October, 19th 2017. View Earnings Estimates for Danaher.

What guidance has Danaher issued on next quarter's earnings?

Danaher issued an update on its FY17 earnings guidance on Thursday, July, 20th. The company provided EPS guidance of $3.90-3.97 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.93. Danaher also updated its Q3 guidance to $0.92-0.96 EPS.

Where is Danaher's stock going? Where will Danaher's stock price be in 2017?

15 analysts have issued 1-year price objectives for Danaher's shares. Their predictions range from $83.00 to $97.00. On average, they expect Danaher's stock price to reach $92.13 in the next twelve months. View Analyst Ratings for Danaher.

What are analysts saying about Danaher stock?

Here are some recent quotes from research analysts about Danaher stock:

  • 1. According to Zacks Investment Research, "Year-to-date, Danaher’s shares have outperformed the industry’s average return. The company has an excellent earnings history over the trailing four quarters, beating estimates all through. We are optimistic about the company’s core revenue and earnings growth, on the back of improving order trends and its operating culture, DBS. Going forward, the company expects the biopharma business to be a major growth driver. Its recent acquisitions - Pall and Cepheid – are proving to be strong profit churners, and will boost top-line growth as they become a part of the company’s core revenues. However, on the flip side, slowdown in the company’s academic business in Europe and prolonged sluggishness in the Dental business has restricted growth. Weakness in industrial markets and stiff competition may also hurt the company's financials." (10/5/2017)
  • 2. Jefferies Group LLC analysts commented, "Following a solid 4Q beat, our '17 forecasts feel incrementally conservative, given strong core margin progress & encouraging signs of better demand in certain industrial pockets. With core growth poised to accelerate in '17 (and '18) & ample margin expansion levers on-hand, we maintain our Buy rating." (2/1/2017)
  • 3. Evercore ISI analysts commented, "DHR delivered a quarter generally consistent with expectations as core growth remains on an upward trajectory, OMx is solid given the flurry of deals over the past 24 months and FCF conversion is elevated (another form of synergy capture from M&A). We believe investors have aptly rewarded the result, with today's move in shares indicative of a flee to safety and predictability in what is otherwise a challenging Healthcare tape. Given potential cyclical upside should global GDP growth accelerate and a reasonably strong B/S to continue capital allocation in 2017 and beyond we believe DHR's elevated valuation is justified and thus it remains our 'Top Pick' within a Tools complex we favor overall. Furthermore, we believe that while the Dental market has proven frustrating, the asset is of high quality and long-term investors will be pleased to either see the business generate improved / superior returns or be monetized (via sale / spin) for more than is implied in current valuation." (1/31/2017)

Who are some of Danaher's key competitors?

Who are Danaher's key executives?

Danaher's management team includes the folowing people:

  • Steven M. Rales, Chairman of the Board
  • Daniel L. Comas, Chief Financial Officer, Executive Vice President
  • Rainer M. Blair, Executive Vice President
  • William K. Daniel II, Executive Vice President
  • Robert S. Lutz, Senior Vice President, Chief Accounting Officer
  • Brian W. Ellis, Senior Vice President, General Counsel
  • Angela S. Lalor, Senior Vice President - Human Resources
  • William H. King, Senior Vice President - Strategic Development
  • Daniel A. Raskas, Senior Vice President - Corporate Development
  • Thomas Patrick Joyce Jr., President, Chief Executive Officer, Director

Who owns Danaher stock?

Danaher's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Park National Corp OH (0.02%), Osborn Williams & Donohoe LLC (0.01%), Neville Rodie & Shaw Inc. (0.01%), Bath Savings Trust Co (0.01%), Curbstone Financial Management Corp (0.00%) and Fulton Bank N.A. (0.00%). Company insiders that own Danaher stock include Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, James A Lico, Linda P Hefner, Robert S Lutz, Thomas Patrick Joyce Jr, Thomas Patrick Joyce, Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.

Who sold Danaher stock? Who is selling Danaher stock?

Danaher's stock was sold by a variety of institutional investors in the last quarter, including Osborn Williams & Donohoe LLC. Company insiders that have sold Danaher stock in the last year include Angela S Lalor, Brian W Ellis, Donald J Ehrlich, Linda P Hefner, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.

Who bought Danaher stock? Who is buying Danaher stock?

Danaher's stock was purchased by a variety of institutional investors in the last quarter, including Park National Corp OH, Bath Savings Trust Co, Fulton Bank N.A., Neville Rodie & Shaw Inc. and Curbstone Financial Management Corp. View Insider Buying and Selling for Danaher.

How do I buy Danaher stock?

Shares of Danaher can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Danaher's stock price today?

One share of Danaher stock can currently be purchased for approximately $85.26.

MarketBeat Community Rating for Danaher (NYSE DHR)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  693 (Vote Outperform)
Underperform Votes:  348 (Vote Underperform)
Total Votes:  1,041
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Danaher (NYSE:DHR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $92.13 (8.05% upside)
Consensus Price Target History for Danaher (NYSE:DHR)
Price Target History for Danaher (NYSE:DHR)
Analysts' Ratings History for Danaher (NYSE:DHR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/6/2017Morgan StanleyReiterated RatingOverweight$86.00 -> $95.00N/AView Rating Details
10/4/2017Cowen and CompanyReiterated RatingBuy$90.00LowView Rating Details
9/26/2017Goldman Sachs Group, Inc. (The)Reiterated RatingNeutral -> Neutral$83.00LowView Rating Details
9/8/2017J P Morgan Chase & CoReiterated RatingOverweight$95.00LowView Rating Details
8/4/2017Jefferies Group LLCReiterated RatingBuy$95.00LowView Rating Details
7/22/2017Wells Fargo & CompanyReiterated RatingMarket PerformLowView Rating Details
7/21/2017Citigroup Inc.Set Price TargetBuy$98.00 -> $96.00LowView Rating Details
7/12/2017Royal Bank Of CanadaReiterated RatingHold$88.00LowView Rating Details
6/21/2017Deutsche Bank AGReiterated RatingBuy$97.00LowView Rating Details
6/7/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
5/24/2017Credit Suisse GroupReiterated RatingBuy$93.00LowView Rating Details
4/23/2017William BlairReiterated RatingOutperformLowView Rating Details
4/23/2017BTIG ResearchReiterated RatingBuy$92.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$88.50 -> $91.50N/AView Rating Details
12/15/2016Sanford C. BernsteinReiterated RatingOutperformN/AView Rating Details
9/7/2016Barclays PLCBoost Price TargetOverweight$90.00 -> $91.00N/AView Rating Details
7/28/2016ArgusReiterated RatingBuy$110.00 -> $90.00N/AView Rating Details
5/29/2016Bank of America CorporationReiterated RatingBuyN/AView Rating Details
4/25/2016Leerink SwannReiterated RatingBuyN/AView Rating Details
4/25/2016Sterne Agee CRTBoost Price TargetNeutral$90.00 -> $97.00N/AView Rating Details
4/22/2016Stifel NicolausBoost Price TargetBuy$109.00 -> $110.00N/AView Rating Details
(Data available from 10/17/2015 forward)


Earnings History for Danaher (NYSE:DHR)
Earnings by Quarter for Danaher (NYSE:DHR)
Earnings History by Quarter for Danaher (NYSE DHR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2017$0.95N/AView Earnings Details
7/20/2017Q2 2017$0.97$0.99$4.50 billion$4.51 billionViewN/AView Earnings Details
4/20/2017Q1 2017$0.84$0.85$4.17 billion$4.21 billionViewN/AView Earnings Details
1/31/2017Q416$1.03$1.05$4.54 billion$4.60 billionViewN/AView Earnings Details
10/20/2016Q316$0.82$0.87$4.14 billion$4.10 billionViewListenView Earnings Details
7/25/2016Q216$1.22$1.25$5.76 billion$5.80 billionViewListenView Earnings Details
4/21/2016Q116$1.03$1.08$5.33 billion$5.39 billionViewListenView Earnings Details
1/26/2016Q415$1.27$1.27$6.03 billion$5.88 billionViewListenView Earnings Details
10/22/2015Q315$1.04$1.05$4.99 billion$5.02 billionViewListenView Earnings Details
7/23/2015Q215$1.04$1.08$5.07 billion$5.13 billionViewListenView Earnings Details
4/23/2015Q115$0.93$0.93$4.84 billion$4.87 billionViewListenView Earnings Details
1/27/2015Q414$1.04$1.04$5.39 billion$5.42 billionViewListenView Earnings Details
10/16/2014Q314$0.90$0.90$4.90 billion$4.90 billionViewListenView Earnings Details
7/17/2014Q214$0.94$0.95$4.97 billion$5.00 billionViewListenView Earnings Details
4/16/2014Q114$0.80$0.81$4.67 billion$4.66 billionViewListenView Earnings Details
1/28/2014Q413$0.95$0.96$5.20 billion$5.27 billionViewListenView Earnings Details
10/17/2013Q313$0.83$0.84$4.61 billion$4.67 billionViewListenView Earnings Details
7/18/2013Q2 2013$0.85$0.87$4.72 billion$4.70 billionViewListenView Earnings Details
4/18/2013Q1 2013$0.76$0.75$4.50 million$4.40 millionViewListenView Earnings Details
1/29/2013Q4 2012$0.86$0.89$4.81 billion$4.98 billionViewListenView Earnings Details
10/18/2012$0.79$0.77ViewN/AView Earnings Details
7/19/2012$0.80$0.84ViewN/AView Earnings Details
4/19/2012$0.71$0.73ViewN/AView Earnings Details
1/31/2012$0.78$0.81ViewN/AView Earnings Details
10/20/2011$0.70$0.73ViewN/AView Earnings Details
7/21/2011$0.67$0.69ViewN/AView Earnings Details
4/21/2011$0.57$0.65ViewN/AView Earnings Details
1/27/2011$0.66$0.67ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Danaher (NYSE:DHR)
2017 EPS Consensus Estimate: $3.93
2018 EPS Consensus Estimate: $4.33
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.84$0.84$0.84
Q2 20172$0.96$0.99$0.98
Q3 20172$0.95$0.95$0.95
Q4 20172$1.16$1.17$1.17
Q1 20181$1.01$1.01$1.01
Q2 20181$1.08$1.08$1.08
Q3 20181$1.06$1.06$1.06
Q4 20181$1.18$1.18$1.18
(Data provided by Zacks Investment Research)


Current Dividend Information for Danaher (NYSE:DHR)
Next Dividend:10/27/2017
Annual Dividend:$0.56
Dividend Yield:0.66%
Dividend Growth:97.80% (3 Year Average)
Payout Ratio:17.83% (Trailing 12 Months of Earnings)
14.14% (Based on This Year's Estimates)
13.05% (Based on Next Year's Estimates)
Track Record:3 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Danaher (NYSE:DHR)

Dividend History by Quarter for Danaher (NYSE DHR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Danaher (NYSE:DHR)
Insider Ownership Percentage: 12.20%
Institutional Ownership Percentage: 75.66%
Insider Trades by Quarter for Danaher (NYSE:DHR)
Institutional Ownership by Quarter for Danaher (NYSE:DHR)
Insider Trades by Quarter for Danaher (NYSE:DHR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/31/2017William KingInsiderSell43,688$82.86$3,619,987.68View SEC Filing  
7/31/2017Thomas Patrick Joyce JrInsiderSell9,772$81.78$799,154.16View SEC Filing  
7/21/2017Linda P HefnerDirectorSell10,578$83.03$878,291.34View SEC Filing  
7/21/2017William KingInsiderSell7,458$82.97$618,790.26View SEC Filing  
5/23/2017Angela S LalorSVPSell10,815$84.16$910,190.40View SEC Filing  
4/25/2017William K DanielEVPSell17,444$83.07$1,449,073.08View SEC Filing  
4/21/2017Donald J EhrlichDirectorBuy600$82.76$49,656.00View SEC Filing  
4/21/2017Thomas Patrick Joyce JrInsiderSell54,006$82.52$4,456,575.12View SEC Filing  
2/28/2017Brian W EllisInsiderSell983$86.00$84,538.00View SEC Filing  
2/24/2017Robert S LutzSVPSell37,870$85.60$3,241,672.00View SEC Filing  
2/15/2017Walter G LohrDirectorSell10,578$84.32$891,936.96View SEC Filing  
2/14/2017Donald J EhrlichDirectorSell10,578$83.98$888,340.44View SEC Filing  
10/21/2016Thomas Patrick Joyce JrInsiderSell36,125$79.68$2,878,440.00View SEC Filing  
8/1/2016Thomas Patrick Joyce JrInsiderSell45,897$81.44$3,737,851.68View SEC Filing  
7/27/2016Daniel L ComasCFOSell96,446$80.88$7,800,552.48View SEC Filing  
5/12/2016Angela S LalorSVPSell8,392$97.77$820,485.84View SEC Filing  
4/27/2016James A LicoEVPSell58,954$96.93$5,714,411.22View SEC Filing  
4/22/2016Daniel L ComasCFOSell89,280$95.71$8,544,988.80View SEC Filing  
4/22/2016Thomas Patrick Joyce JrCEOSell14,630$95.50$1,397,165.00View SEC Filing  
4/22/2016William K DanielEVPSell41,140$96.06$3,951,908.40View SEC Filing  
4/22/2016William KingSVPSell6,000$96.31$577,860.00View SEC Filing  
2/29/2016James A LicoEVPSell60,000$89.24$5,354,400.00View SEC Filing  
2/26/2016Daniel RaskasSVPSell4,656$89.00$414,384.00View SEC Filing  
2/26/2016Walter G LohrDirectorSell8,000$89.06$712,480.00View SEC Filing  
2/10/2016Donald J. EhrlichDirectorSell8,000$86.00$688,000.00View SEC Filing  
1/27/2016Thomas Patrick Joyce, Jr.CEOSell25,300$83.98$2,124,694.00View SEC Filing  
11/24/2015James A. LicoEVPSell55,840$96.40$5,382,976.00View SEC Filing  
10/30/2015William K. DanielEVPSell39,740$93.04$3,697,409.60View SEC Filing  
10/23/2015Daniel L. ComasCFOSell36,200$92.71$3,356,102.00View SEC Filing  
10/23/2015Robert S. LutzCAOSell26,400$93.45$2,467,080.00View SEC Filing  
10/23/2015Thomas Patrick Joyce, Jr.CEOSell25,300$93.47$2,364,791.00View SEC Filing  
7/24/2015Thomas Patrick Joyce JrCEOSell25,300$88.20$2,231,460.00View SEC Filing  
7/24/2015William K DanielEVPSell15,000$88.40$1,326,000.00View SEC Filing  
7/24/2015William KingSVPSell4,000$88.00$352,000.00View SEC Filing  
5/28/2015Angela S LalorSVPSell5,959$87.06$518,790.54View SEC Filing  
5/22/2015Walter G LohrDirectorSell8,000$87.00$696,000.00View SEC Filing  
5/19/2015Jonathan P GrahamVPSell30,232$86.89$2,626,858.48View SEC Filing  
5/15/2015Jonathan P GrahamVPSell185,620$87.73$16,284,442.60View SEC Filing  
4/24/2015Daniel L ComasCFOSell25,000$83.50$2,087,500.00View SEC Filing  
4/24/2015Thomas Patrick Joyce JrCEOSell43,945$83.81$3,683,030.45View SEC Filing  
4/24/2015William K DanielEVPSell58,400$83.33$4,866,472.00View SEC Filing  
2/26/2015Daniel RaskasSVPSell4,179$87.79$366,874.41View SEC Filing  
2/24/2015Jonathan P GrahamVPSell9,961$86.77$864,315.97View SEC Filing  
2/20/2015Daniel RaskasSVPSell56,000$87.03$4,873,680.00View SEC Filing  
2/3/2015Donald J EhrlichDirectorSell8,000$84.82$678,560.00View SEC Filing  
2/2/2015James A LicoEVPSell98,000$82.64$8,098,720.00View SEC Filing  
2/2/2015Walter G LohrDirectorSell8,000$82.30$658,400.00View SEC Filing  
1/28/2015Daniel L ComasCFOSell75,000$84.59$6,344,250.00View SEC Filing  
11/20/2014James H DitkoffVPSell3,606$82.35$296,954.10View SEC Filing  
11/3/2014Thomas Patrick Joyce JrCEOSell50,000$79.97$3,998,500.00View SEC Filing  
10/29/2014Angela S LalorSVPSell8,450$79.45$671,352.50View SEC Filing  
8/1/2014William KingSVPSell3,545$73.74$261,408.30View SEC Filing  
7/18/2014H Lawrence Culp JrCEOSell111,540$74.14$8,269,575.60View SEC Filing  
5/28/2014John T SchwietersDirectorSell8,000$78.73$629,840.00View SEC Filing  
5/12/2014Jonathan GrahamVPSell9,973$75.00$747,975.00View SEC Filing  
5/1/2014Daniel RaskasSVPSell11,158$73.48$819,889.84View SEC Filing  
2/25/2014Robert LutzCAOSell6,250$76.85$480,312.50View SEC Filing  
10/24/2013Daniel L ComasCFOSell50,000$71.65$3,582,500.00View SEC Filing  
10/18/2013Daniel RaskasSVPSell20,000$71.99$1,439,800.00View SEC Filing  
8/29/2013Donald EhrlichDirectorSell8,000$65.25$522,000.00View SEC Filing  
8/6/2013Thomas Patrick Joyce, Jr.EVPSell48,000$67.04$3,217,920.00View SEC Filing  
7/24/2013Daniel RaskasSVPSell20,000$67.54$1,350,800.00View SEC Filing  
7/22/2013Daniel L ComasCFOSell54,540$68.14$3,716,355.60View SEC Filing  
7/19/2013Robert S LutzCAOSell5,852$68.57$401,271.64View SEC Filing  
7/1/2013James A LicoEVPSell50,000$64.66$3,233,000.00View SEC Filing  
5/21/2013Daniel L ComasCFOSell55,000$63.89$3,513,950.00View SEC Filing  
5/16/2013Walter G LohrDirectorSell8,000$62.72$501,760.00View SEC Filing  
5/15/2013H Lawrence Culp JrCEOSell500,000$61.92$30,960,000.00View SEC Filing  
5/13/2013James A LicoEVPSell22,519$61.75$1,390,548.25View SEC Filing  
2/25/2013Jonathan P GrahamVPSell7,295$61.38$447,767.10View SEC Filing  
2/25/2013Thomas Patrick Joyce JrEVPSell20,723$61.24$1,269,076.52View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Danaher (NYSE:DHR)
Latest Headlines for Danaher (NYSE:DHR)
finance.yahoo.com logoIs Danaher Set to Beat Q3 Earnings on Life Sciences Growth?
finance.yahoo.com - October 17 at 6:39 PM
nasdaq.com logo4 Stocks From 4 Top Sectors Set to Beat This Earnings Season (Revised)
www.nasdaq.com - October 13 at 6:26 PM
thestreet.com logoMicrochip Technology Achieves #93 Analyst Rank, Surpassing Danaher
www.thestreet.com - October 13 at 6:26 PM
finance.yahoo.com logoDanaher Corp. : DHR-US: Dividend Analysis : September 29th, 2017 (record date) : By the numbers : October 13, 2017
finance.yahoo.com - October 13 at 6:26 PM
americanbankingnews.com logoDanaher Corporation (DHR) to Release Earnings on Thursday
www.americanbankingnews.com - October 12 at 1:24 AM
finance.yahoo.com logoGE Nears 2-Year Low: Value Stock or Value Trap?
finance.yahoo.com - October 12 at 12:25 AM
investorplace.com logoAnalysts Keep Danaher Corporation (DHR) Sell Rating - Investorplace.com
investorplace.com - October 11 at 7:24 PM
finance.yahoo.com logo4 Stocks from 4 Top Sectors Set to Beat This Earnings Season
finance.yahoo.com - October 11 at 7:24 PM
americanbankingnews.com logoMorgan Stanley Reaffirms "Overweight" Rating for Danaher Corporation (DHR)
www.americanbankingnews.com - October 7 at 12:22 PM
americanbankingnews.com logoDanaher Corporation (DHR) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - October 5 at 1:33 PM
americanbankingnews.com logoMindray Medical International (MR) vs. Danaher Corporation (DHR) Financial Comparison
www.americanbankingnews.com - October 2 at 10:48 AM
americanbankingnews.com logoDanaher Corporation (DHR) Earns Neutral Rating from Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - October 1 at 11:34 PM
americanbankingnews.com logoDanaher Corporation (DHR) Expected to Post Earnings of $0.95 Per Share
www.americanbankingnews.com - October 1 at 6:30 PM
nasdaq.com logoDanaher Corporation (DHR) Ex-Dividend Date Scheduled for September 28, 2017 - Nasdaq
www.nasdaq.com - September 28 at 5:35 PM
americanbankingnews.com logoFinancial Survey: Danaher Corporation (DHR) and Boston Scientific Corporation (BSX)
www.americanbankingnews.com - September 28 at 2:28 PM
americanbankingnews.com logoDanaher Corporation (DHR) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 27 at 9:04 PM
nasdaq.com logoEx-Dividend Reminder: Algonquin Power & Utilities, National Fuel Gas and Danaher
www.nasdaq.com - September 27 at 6:42 PM
americanbankingnews.com logoFinancial Survey: Danaher Corporation (DHR) versus Its Peers
www.americanbankingnews.com - September 22 at 8:20 PM
finance.yahoo.com logoDanaher Schedules Third Quarter 2017 Earnings Conference Call
finance.yahoo.com - September 20 at 6:41 PM
americanbankingnews.com logoDanaher Corporation Announces Quarterly Dividend of $0.14 (DHR)
www.americanbankingnews.com - September 12 at 4:44 PM
seekingalpha.com logoDanaher Corporation declares $0.14 dividend
seekingalpha.com - September 12 at 4:21 PM
americanbankingnews.com logoFinancial Contrast: Danaher Corporation (DHR) & Thermo Fisher Scientific (TMO)
www.americanbankingnews.com - September 11 at 6:44 PM
benzinga.com logoDanaher Was Just Added To An Important JP Morgan List; Here's ... - Benzinga
www.benzinga.com - September 9 at 4:22 AM
americanbankingnews.com logoDanaher Corporation (DHR) Given Overweight Rating at J P Morgan Chase & Co
www.americanbankingnews.com - September 8 at 10:34 PM
finance.yahoo.com logoDanaher Was Just Added To An Important JP Morgan List; Here's Why
finance.yahoo.com - September 8 at 6:14 PM
finance.yahoo.com logoDanaher Corp. – Value Analysis (NYSE:DHR) : September 6, 2017
finance.yahoo.com - September 6 at 12:23 AM
americanbankingnews.com logoDanaher Corporation (DHR) Insider Sells $3,619,987.68 in Stock
www.americanbankingnews.com - September 5 at 7:23 PM
americanbankingnews.com logoDanaher Corporation (DHR) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 2 at 6:30 PM
finance.yahoo.com logoDanaher Corp. breached its 50 day moving average in a Bullish Manner : DHR-US : September 1, 2017
finance.yahoo.com - September 1 at 6:11 PM
prnewswire.com logoDanaher To Present At Vertical Research Partners Industrial Conference - PR Newswire (press release)
www.prnewswire.com - August 31 at 10:50 PM
finance.yahoo.com logoDanaher To Present At Vertical Research Partners Industrial Conference
finance.yahoo.com - August 31 at 5:48 PM
americanbankingnews.com logo Analysts Expect Danaher Corporation (DHR) Will Post Quarterly Sales of $4.46 Billion
www.americanbankingnews.com - August 27 at 5:52 AM
nasdaq.com logoDanaher (DHR) Down 2.8% Since Earnings Report: Can It Rebound ... - Nasdaq
www.nasdaq.com - August 23 at 4:27 AM
finance.yahoo.com logoDanaher (DHR) Down 2.8% Since Earnings Report: Can It Rebound?
finance.yahoo.com - August 21 at 5:32 PM
americanbankingnews.com logoDanaher Corporation (DHR) Short Interest Update
www.americanbankingnews.com - August 16 at 1:54 AM
finance.yahoo.com logoETFs with exposure to Danaher Corp. : August 14, 2017
finance.yahoo.com - August 14 at 6:13 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Danaher Corp.
finance.yahoo.com - August 12 at 5:16 PM
americanbankingnews.com logo Analysts Expect Danaher Corporation (NYSE:DHR) Will Announce Quarterly Sales of $4.46 Billion
www.americanbankingnews.com - August 9 at 7:52 AM
americanbankingnews.com logoDanaher Corporation (DHR) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - August 8 at 8:40 PM
nasdaq.com logoDanaher Enters Oversold Territory (DHR) - Nasdaq
www.nasdaq.com - August 8 at 5:36 PM
finance.yahoo.com logoAcquisitions and Steady Business Operations Help Danaher
finance.yahoo.com - August 6 at 9:57 PM
americanbankingnews.com logoDanaher Corporation (DHR) Earns "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - August 6 at 12:34 AM
finance.yahoo.com logoETFs with exposure to Danaher Corp. : August 4, 2017
finance.yahoo.com - August 3 at 9:55 PM
americanbankingnews.com logoDanaher Corporation (DHR) Insider Thomas Patrick Joyce, Jr. Sells 9,772 Shares
www.americanbankingnews.com - August 1 at 7:28 PM
finance.yahoo.com logoLeucadia (LUK) Misses Q2 Earnings Estimates, Revenues Beat
finance.yahoo.com - July 28 at 7:54 PM
americanbankingnews.com logoDanaher Corporation (NYSE:DHR) & Alliance HealthCare Services (AIQ) Head-To-Head Survey
www.americanbankingnews.com - July 26 at 6:29 PM
fool.com logoAfter Disappointing Earnings, Is Danaher Corporation Still Worth Investing In? - Motley Fool
www.fool.com - July 26 at 6:28 PM
seekingalpha.com logoDanaher In Some Doldrums - Seeking Alpha
seekingalpha.com - July 26 at 6:28 PM
fool.com logoAfter Disappointing Earnings, Is Danaher Corporation Still Worth Investing In?
www.fool.com - July 25 at 7:52 AM
americanbankingnews.com logoDanaher Corporation (DHR) Insider William King Sells 7,458 Shares
www.americanbankingnews.com - July 24 at 7:28 PM



Danaher (DHR) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.